BGIM
ATNM icon

Brandywine Global Investment Management’s Actinium Pharmaceuticals ATNM Stock Holding History

Brandywine Global Investment Management’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-89,700
Closed -$169K – 569
2024
Q3 		$169K Sell
89,700
-38,500
-30% -$152K ﹤0.01% 651
2024
Q2 		$949K Sell
128,200
-17,400
-12% -$143K 0.01% 632
2024
Q1 		$1.14M Hold
145,600
– – 0.01% 626
2023
Q4 		$740K Sell
145,600
-28,900
-17% -$149K 0.01% 654
2023
Q3 		$1.03M Buy
+174,500
New +$1.16M 0.01% 629

Other funds holding ATNM

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $25.4B AUM 38.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Squarepoint
Squarepoint New York $46.5B AUM 20.93% 1-Year Est. Return